Position in INSM
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$8,529
-$791 QoQ
Shares Held
80
+40.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#559
of 663 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Fourth Dimension Wealth, LLC holds $59,831 across 9 Biotechnology names. INSM ranks #3 (14.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
180 | $20,404 | |
| 2 | JANX |
Janux Therapeutics, Inc.
|
600 | $9,216 | |
| 3 | INSM |
INSMED Inc
This page
|
80 | $8,529 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
11 | $6,858 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
22 | $6,622 | |
| 6 | MDXG |
Mimedx Group, Inc.
|
700 | $2,695 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
10 | $2,409 | |
| 8 | KYTX |
Kyverna Therapeutics, Inc.
|
250 | $2,227 |
All Filings in INSM
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,529 | 80 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $9,320 | 57 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $9,920 | 57 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $8,208 | 57 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $234,692 | 2,332 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $123,742 | 1,622 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $277,609 | 4,021 | Shares | Sole | 2025-02-18 | |
| No filing history on record for this holder in this stock. | ||||||